The study indicated that pulmonary fibrosis (median 4.2 ng/ mL) and COPD (median 3.0 ng/mL) could easily lead to CEA elevations, which in some cases could exceed the median CEA of certain tumors. The gene discussed is CEACAM5; the disease is chronic obstructive pulmonary disease.